Friday, 13 November 2026 Partly cloudyNew Delhi 22° New DelhiLondonNew YorkDubaiTokyo
INDEPENDENT THINKING.
SHARED UNDERSTANDING.International edition · Correspondents across India and around the world
RationalTimes●
A little less noise.
A little more perspective. Join our media house
BREAKING
VerifiedNavy Conducts Sea Vigil Exercise In Bay Of Bengal Off Vizag VerifiedPaddy, Rice, Pulses Control Comes In Verified‘Sunset P.I.’ Sets NBC Release Date, Jake Johnson Comedy Series Drops New First-Look Photos VerifiedEstonia latest country to ban Russian athletes VerifiedFMG Interns Call Off Strike After Meeting Health Minister ClimateCOP31 climate talks open in Antalya, Türkiye, on 9 November USAmericans vote in the midterm elections on 3 November TechnologyNorth Korea-linked hackers steal about $6.4 billion from Binance in the biggest crypto theft on record, analysts say WorldSpain mourns after a high-speed train ploughs into a stationary train near Toledo, killing at least 68 WorldIsrael’s election ends without a clear winner as exit polls leave both blocs short of a majority WorldSaudi Arabia intercepts Houthi missiles and drones as Egypt’s parliament backs military support PoliticsLula wins Brazil’s presidential runoff as Flávio Bolsonaro concedes
Developing · 1 outletHealth

STAT+: FDA approves novel Bayer drug to reduce recurrence of stroke

Headline via STAT · first report 10 Nov, 03:58 IST, latest 10 Nov, 19:55 IST

All India Institute of Medical Sciences, New Delhi
Representational image · All India Institute of Medical Sciences, New Delhi · Baap8969 / Wikimedia Commons, CC0

What we know

So far only STAT has reported this (10 Nov, 03:58 IST). It will be marked Verified when a second, independent news organisation reports it. Rational Times has not independently confirmed the details: read each report through the links below.

StatusDeveloping
Reported by1 news organisation
First report10 Nov, 03:58 IST
Latest report10 Nov, 19:55 IST
DeskHealth

What the reports sayEach newsroom’s own summary of its report, from its feed

Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.

Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.

About CultureHealth 10 Nov 2026

The reports2 reports

Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake

Read nextThe biggest stories right now